Biomarkers for antitumor activity of bevacizumab in gastric cancer models

Abstract

VEGF levels and VEGF/bFGF ratios in tumors were related to bevacizumab sensitivity of the xenografts tested. Further clinical investigation into useful predictive markers for bevacizumab sensitivity is warranted.